Miller v. Abbott Laboratories et al
| BARRY MILLER |
| TAKEDA DEVELOPMENT CENTER AMERICAS INC., ABBOTT LABORATORIES, TAKEDA PHARMACEUTICALS AMERICA, INC, ASTRAZENECA LP, TAKEDA PHARMACEUTICAL COMPANY LIMITED, MERCK & CO., INC. doing business as Merck, Sharpe & Dohme Corporation, ASTRAZENECA PHARMACEUTICALS LP, PFIZER, INC., TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER INC. and TAKEDA PHARMACEUTICALS U.S.A, INC. |
| PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (No. II) |
| 2:2021cv00219 |
| January 6, 2021 |
| US District Court for the District of New Jersey |
| Claire C Cecchi |
| Mark Falk |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Defendant |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 6, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 Clerk's Notice to Counsel. (gh, ) |
| Filing 10 Certified Copy of Transfer Order and docket received, Case transferred in from District of Illinois Northern; Case Number 1:20-cv-07587. Original file certified copy of transfer order and docket sheet received. |
| Filing 9 TRANSFERRED to the USDC New Jersey, Newark Division the Electronic Record. (rc, ) |
| Member Case Transferred in on 1/6/21 from the Northern District if Illinois 1:20-cv-07587 for MDL 2789 PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (No. II) (gh, ) |
| Judge Claire C. Cecchi and Chief Mag. Judge Mark Falk added. (gh, ) |
| For all Case Management Orders #click here (gh, ) |
| Filing 8 CONDITIONAL TRANSFER ORDER from MDL Panel transferring case to United States District Court for the District of New Jersey. Mailed notice (rc, ) |
| Civil case terminated. Mailed notice (rc, ) |
| Filing 7 MINUTE entry before the Honorable Steven C. Seeger: An initial status report is due by March 8, 2021. Counsel must read the Standing Order entitled "Initial Status Conferences and Joint Initial Status Reports" on the Court's website. The parties must confer as required by Rule 26(f) about the nature, scope, and duration of discovery. The parties must submit two documents to the Court. First, the parties must file the Joint Initial Status Report under Rule 26(f) on the docket. A Word version of the Joint Initial Status Report is available on the Court's website. All parties must participate in the preparation and filing of the Joint Initial Status Report. The Court requires a joint report, so a filing by one side or the other is not sufficient. Second, the parties must email a Word version of a proposed Scheduling Order under Rule 16(b) to the Court's proposed order inbox. Lead counsel for the parties must participate in filing the initial status report. Plaintiff must serve this Order on all other parties. If the defendant has not been served with process, plaintiff's counsel must contact the Courtroom Deputy at jessica_j_ramos@ilnd.uscourts.gov to reschedule the initial status report deadline. Plaintiff should not file the Joint Initial Status Report before the defendant(s) has been served with process. The parties must discuss settlement in good faith and make a serious attempt to resolve this case amicably. All counsel of record must read and comply with this Court's Standing Orders on its webpage. Please pay special attention to the Standing Orders about Depositions and Discovery. Mailed notice. (jjr, ) |
| Filing 6 MAILED Notice of Removal Letter to Plaintiff's Counsel, Samuel Geisler and Paul J. Pennock. (jh, ) |
| CASE ASSIGNED to the Honorable Steven C. Seeger. Designated as Magistrate Judge the Honorable M. David Weisman. Case assignment: Random assignment. (cp, ) |
| Filing 5 ATTORNEY Appearance for Defendants Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. by Sherry Ann Knutson (Knutson, Sherry) |
| Filing 4 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. (Hemmings, James) |
| Filing 3 ATTORNEY Appearance for Defendants Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. by James R M Hemmings (Hemmings, James) |
| Filing 2 CIVIL Cover Sheet (Hemmings, James) |
| Filing 1 NOTICE of Removal from Circuit Court of Cook County, Illinois, case number (2019-L-005985) filed by Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. Filing fee $ 402, receipt number 0752-17761744. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit)(Hemmings, James) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
